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The original version of this article unfortunately contained a mistake. The presentation of Table 2 was incorrect. The corrected Table [2](#Tab1){ref-type="table"} is given below. The original article has been corrected.Table 2Surgical delay, length of hospital stay, type of anaesthesia, perioperative complications and mortality reported among hip fracture with DOAC or no anticoagulation prior to the fracture (*n* = 314)Antithrombotic medicationHospital stayTotalNo anticoagulantsDOAC*p* valueHours from admission to surgery (SD)26.5 (18.2)26.1 (19.0)28.9 (12.9)0.26LOS (SD)6.2 (2.9)6.1 (2.9)6.6 (2.2)0.34General anaesthesia (%)**32 (10%)10 (3.8%)22 (47%)0.001**Perioperative complications*p* valueMean blood loss during surgery (SD)219 mL (208)218 mL (209)223 mL (204)0.9Mean fall in haemoglobin (SD)1.90 (1.30)1.89 (1.25)1.95 (1.63)0.8Mean SAG transfused per patient (SD)0.81 (1.16)0.80 (1.17)0.85 (1.10)0.8OR (95% CI)Number of patients transfused (%)134 (43%)113 (42%)21 (45%)1.10 (0.59--2.01)Reported wound ooze (%)**27 (8.6%)15 (5.6%)12 (26%)5.8 (2.49--13.3)**MortalityOR (95% CI)In-hospital mortality11 (3.5%)9 (3.4%)2 (4.3%)1.27 (0.27--6.09)30-day mortality39 (12.4%)34 (12.7%)5 (10.6%)1.23 (0.45--3.31)6-month mortality70 (22.3%)59 (22.1%)11 (23.4%)0.93 (0.45--1.94)Bold values indicate more frequent use of general anaesthesia and higher risk of wound ooze in DOAC-users compared to non-users
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